Literature DB >> 1570520

Contribution of synovial mesenchymal cells to the pathogenesis of rheumatoid arthritis.

S Shiozawa1, T Tokuhisa.   

Abstract

Rheumatoid joint destruction is caused by (1) enzymatic digestion from articular surfaces of cartilage, (2) pannus formation, and (3) lysis of the matrix by activated chondrocytes. Pannus, a vascular and fibrous granulation tissue arising from the perichondral synovial membrane, extends onto cartilage surfaces as a layer of morphologically quiescent fibroblastic mesenchymal cells. Pannus subsequently starts invasion into cartilage matrix with the appearance of macrophagelike cells. Synovial mesenchymal cells are thought to play important roles in the pathogenesis of rheumatoid joint destruction in relation to la expression and antigen presentation as well as the elaboration of inflammatory cytokines such as interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha. By experimentally inducing antigen-induced arthritis in H-2-c-fos transgenic mice whose immunoglobulin G antibody response against immunizing antigen was defective, the investigators produced destructive arthritis without lymphocyte infiltration. The only cells invading the joints in these mice were similar to a previously recognized subset of human synovial cells that had a mesenchymal appearance. These mesenchymal cells invaded the cartilage matrix upon in vitro culture. The role of synovial mesenchymal cells in the pathogenesis of rheumatoid joint destruction is discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1570520     DOI: 10.1016/0049-0172(92)90058-l

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  8 in total

1.  Studies on the contribution of c-fos/AP-1 to arthritic joint destruction.

Authors:  S Shiozawa; K Shimizu; K Tanaka; K Hino
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

2.  TGFbeta1 regulates gene expression of its own converting enzyme furin.

Authors:  F Blanchette; R Day; W Dong; M H Laprise; C M Dubois
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

3.  Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes.

Authors:  C Xue; M Takahashi; T Hasunuma; H Aono; K Yamamoto; S Yoshino; T Sumida; K Nishioka
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

4.  Pathogenic importance of fibronectin in the superficial region of articular cartilage as a local factor for the induction of pannus extension on rheumatoid articular cartilage.

Authors:  S Shiozawa; R Yoshihara; Y Kuroki; T Fujita; K Shiozawa; S Imura
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

5.  Bone marrow cells carrying the env-pX transgene play a role in the severity but not prolongation of arthritis in human T-cell leukaemia virus type-I transgenic rats: a possible role of articular tissues carrying the transgene in the prolongation of arthritis.

Authors:  Asami Abe; Akihiro Ishizu; Hitoshi Ikeda; Hiroko Hayase; Takahiro Tsuji; Yukiko Miyatake; Muneharu Tsuji; Kazunori Fugo; Toshiaki Sugaya; Masato Higuchi; Takeo Matsuno; Takashi Yoshiki
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

6.  Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures.

Authors:  O Elkayam; I Yaron; I Shirazi; R Judovitch; D Caspi; M Yaron
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

7.  How could infectious agents hide in synovial cells? Possible mechanisms of persistent viral infection in a model for the etiopathogenesis of chronic arthritis.

Authors:  H I Huppertz
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  Modulation of Apoptosis and Differentiation by the Treatment of Sulfasalazine in Rabbit Articular Chondrocytes.

Authors:  Won Kil Lee; Jin Seok Kang
Journal:  Toxicol Res       Date:  2016-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.